Found: 33
Select item for more details and to access through your institution.
Berichtigung: Sterilizing Immunity against SARS‐CoV‐2 Infection in Mice by a Single‐Shot and Lipid Amphiphile Imidazoquinoline TLR7/8 Agonist‐Adjuvanted Recombinant Spike Protein Vaccine.
- Published in:
- Angewandte Chemie, 2021, v. 133, n. 31, p. 16878, doi. 10.1002/ange.202105635
- By:
- Publication type:
- Article
Sterilizing Immunity against SARS‐CoV‐2 Infection in Mice by a Single‐Shot and Lipid Amphiphile Imidazoquinoline TLR7/8 Agonist‐Adjuvanted Recombinant Spike Protein Vaccine.
- Published in:
- Angewandte Chemie, 2021, v. 133, n. 17, p. 9553, doi. 10.1002/ange.202015362
- By:
- Publication type:
- Article
A Newcastle Disease Virus (NDV) Expressing a Membrane-Anchored Spike as a Cost-Effective Inactivated SARS-CoV-2 Vaccine.
- Published in:
- Vaccines, 2020, v. 8, n. 4, p. 771, doi. 10.3390/vaccines8040771
- By:
- Publication type:
- Article
Monoclonal antibodies targeting the influenza virus N6 neuraminidase.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.944907
- By:
- Publication type:
- Article
Sustained Antibody-Dependent NK Cell Functions in Mild COVID-19 Outpatients During Convalescence.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.796481
- By:
- Publication type:
- Article
Detection of Antibody Responses Against SARS-CoV-2 in Plasma and Saliva From Vaccinated and Infected Individuals.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.759688
- By:
- Publication type:
- Article
A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-26499-y
- By:
- Publication type:
- Article
Functionality of the putative surface glycoproteins of the Wuhan spiny eel influenza virus.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-26409-2
- By:
- Publication type:
- Article
Immunological imprinting of the antibody response in COVID-19 patients.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-23977-1
- By:
- Publication type:
- Article
Vaccination with SARS-CoV-2 variants of concern protects mice from challenge with wild-type virus.
- Published in:
- PLoS Biology, 2021, v. 19, n. 12, p. 1, doi. 10.1371/journal.pbio.3001384
- By:
- Publication type:
- Article
Cross-Reactive Antibodies Binding to the Influenza Virus Subtype H11 Hemagglutinin.
- Published in:
- Pathogens, 2019, v. 8, n. 4, p. 199, doi. 10.3390/pathogens8040199
- By:
- Publication type:
- Article
Dynamic Assay for Profiling Anti-SARS-CoV-2 Antibodies and Their ACE2/Spike RBD Neutralization Capacity.
- Published in:
- Viruses (1999-4915), 2021, v. 13, n. 7, p. 1371, doi. 10.3390/v13071371
- By:
- Publication type:
- Article
A 10-Minute "Mix and Read" Antibody Assay for SARS-CoV-2.
- Published in:
- Viruses (1999-4915), 2021, v. 13, n. 2, p. 143, doi. 10.3390/v13020143
- By:
- Publication type:
- Article
Pre-existing Antineuraminidase Antibodies Are Associated With Shortened Duration of Influenza A(H1N1)pdm Virus Shedding and Illness in Naturally Infected Adults.
- Published in:
- Clinical Infectious Diseases, 2020, v. 70, n. 11, p. 2290, doi. 10.1093/cid/ciz639
- By:
- Publication type:
- Article
Corrigendum: Sterilizing Immunity against SARS‐CoV‐2 Infection in Mice by a Single‐Shot and Lipid Amphiphile Imidazoquinoline TLR7/8 Agonist‐Adjuvanted Recombinant Spike Protein Vaccine.
- Published in:
- Angewandte Chemie International Edition, 2021, v. 60, n. 31, p. 16741, doi. 10.1002/anie.202105635
- By:
- Publication type:
- Article
Sterilizing Immunity against SARS‐CoV‐2 Infection in Mice by a Single‐Shot and Lipid Amphiphile Imidazoquinoline TLR7/8 Agonist‐Adjuvanted Recombinant Spike Protein Vaccine.
- Published in:
- Angewandte Chemie International Edition, 2021, v. 60, n. 17, p. 9467, doi. 10.1002/anie.202015362
- By:
- Publication type:
- Article
Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-92740-9
- By:
- Publication type:
- Article
Inhibition of HECT E3 ligases as potential therapy for COVID-19.
- Published in:
- Cell Death & Disease, 2021, v. 12, n. 4, p. 1, doi. 10.1038/s41419-021-03513-1
- By:
- Publication type:
- Article
Asymptomatic Seroconversion of Immunoglobulins to SARS-CoV-2 in a Pediatric Dialysis Unit.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Anti‐SARS‐CoV‐2 spike antibodies are stable in convalescent plasma when stored at 4° Celsius for at least 6 weeks.
- Published in:
- Transfusion, 2020, v. 60, n. 10, p. 2457, doi. 10.1111/trf.16047
- By:
- Publication type:
- Article
A CpG 1018 adjuvanted neuraminidase vaccine provides robust protection from influenza virus challenge in mice.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00486-w
- By:
- Publication type:
- Article
Robust correlations across six SARS‐CoV‐2 serology assays detecting distinct antibody features.
- Published in:
- Clinical & Translational Immunology, 2021, v. 10, n. 3, p. 1, doi. 10.1002/cti2.1258
- By:
- Publication type:
- Article
The IgA in milk induced by SARS-CoV-2 infection is comprised of mainly secretory antibody that is neutralizing and highly durable over time.
- Published in:
- PLoS ONE, 2022, v. 17, n. 3, p. 1, doi. 10.1371/journal.pone.0249723
- By:
- Publication type:
- Article
Heterologous Ad26/Ad5 adenovirus-vectored vaccines elicited SARS-CoV-2-specific antibody responses with potent Fc activities.
- Published in:
- Frontiers in Immunology, 2024, p. 01, doi. 10.3389/fimmu.2024.1382619
- By:
- Publication type:
- Article
SARS-CoV-2 serosurvey across multiple waves of the COVID-19 pandemic in New York City between 2020–2023.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-50052-2
- By:
- Publication type:
- Article
mRNA-1273 and BNT162b2 COVID-19 vaccines elicit antibodies with differences in Fc-mediated effector functions.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 645, p. 1, doi. 10.1126/scitranslmed.abm2311
- By:
- Publication type:
- Article
Intranasal ChAdOx1 nCoV-19/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models.
- Published in:
- Science Translational Medicine, 2021, v. 13, n. 607, p. 1, doi. 10.1126/scitranslmed.abh0755
- By:
- Publication type:
- Article
Differential T-Cell Reactivity to Endemic Coronaviruses and SARS-CoV-2 in Community and Health Care Workers.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Role of Immunoglobulin M and A Antibodies in the Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2.
- Published in:
- 2021
- By:
- Publication type:
- journal article
A High-Throughput Assay for Circulating Antibodies Directed Against the S Protein of Severe Acute Respiratory Syndrome Coronavirus 2.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Serological identification of SARS-CoV-2 infections among children visiting a hospital during the initial Seattle outbreak.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. N.PAG, doi. 10.1038/s41467-020-18178-1
- By:
- Publication type:
- Article
Broad cross-reactive IgG responses elicited by adjuvanted vaccination with recombinant influenza hemagglutinin (rHA) in ferrets and mice.
- Published in:
- PLoS ONE, 2018, v. 13, n. 4, p. 1, doi. 10.1371/journal.pone.0193680
- By:
- Publication type:
- Article
An immuno-assay to quantify influenza virus hemagglutinin with correctly folded stalk domains in vaccine preparations.
- Published in:
- PLoS ONE, 2018, v. 13, n. 4, p. 1, doi. 10.1371/journal.pone.0194830
- By:
- Publication type:
- Article